chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Muscular weakness, Pain in extremity, SARS-CoV-2 test, Vision blurred
Clinical narrative: Loss of taste; Loss of smell; Sore arm; Light headed; Blurred vision; Weak knees; High BP (145); Swollen eyes; This spontaneous case was reported by an other health care professional and describes the occurrence of DIZZINESS (Light headed), VISION BLURRED (Blurred vision), MUSCULAR WEAKNESS (Weak knees), HYPERTENSION (High BP (145)) and EYE SWELLING (Swollen eyes) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included FENOFIBRATE, SERTRALINE, LOSARTAN and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced DIZZINESS (Light headed), VISION BLURRED (Blurred vision), MUSCULAR WEAKNESS (Weak knees), HYPERTENSION (High BP (145)), EYE SWELLING (Swollen eyes) and PAIN IN EXTREMITY (Sore arm). On 11-Feb-2021, the patient experienced AGEUSIA (Loss of taste) and ANOSMIA (Loss of smell). On 08-Feb-2021, DIZZINESS (Light headed), VISION BLURRED (Blurred vision), MUSCULAR WEAKNESS (Weak knees), HYPERTENSION (High BP (145)) and EYE SWELLING (Swollen eyes) had resolved. At the time of the report, AGEUSIA (Loss of taste), ANOSMIA (Loss of smell) and PAIN IN EXTREMITY (Sore arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Feb-2021, Blood pressure measurement: 145 High. On 16-Feb-2021, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain
Clinical narrative: Slight soreness; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Slight soreness) and CHILLS (Chills) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced PAIN (Slight soreness) and CHILLS (Chills). At the time of the report, PAIN (Slight soreness) and CHILLS (Chills) outcome was unknown.      No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-017462 (Patient Link).
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction (No Medical history reported.).    On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown. Not Provided          Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Erythema, Pruritus, Rash, Vaccination site rash
Clinical narrative: It burns; Rash on their upper back; It itches like crazy; Its red; Rash on the place where they got the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (It burns), RASH (Rash on their upper back), PRURITUS (It itches like crazy), ERYTHEMA (Its red) and VACCINATION SITE RASH (Rash on the place where they got the vaccine) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0ILM20A) for COVID-19 vaccination.     No medical history reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced BURNING SENSATION (It burns), RASH (Rash on their upper back), PRURITUS (It itches like crazy), ERYTHEMA (Its red) and VACCINATION SITE RASH (Rash on the place where they got the vaccine). At the time of the report, BURNING SENSATION (It burns), RASH (Rash on their upper back), PRURITUS (It itches like crazy), ERYTHEMA (Its red) and VACCINATION SITE RASH (Rash on the place where they got the vaccine) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment details included alcohol topical and some lotion.  No relevant concomitant medications were reported.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Tested positive for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID-19) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No medical history reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced COVID-19 (Tested positive for COVID-19). At the time of the report, COVID-19 (Tested positive for COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Feb-2021, SARS-CoV-2 test: Positive.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No relevant concomitant medications were reported.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: A little soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (A little soreness at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No prior medical history was reported.).    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced VACCINATION SITE PAIN (A little soreness at the injection site). On 19-Feb-2021, VACCINATION SITE PAIN (A little soreness at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.  Treatment information was not provided.   The reporter wish to know whether she can have cocktail.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Oropharyngeal pain, Swelling
Clinical narrative: Headache; Neck Swelling (Sore throat); Neck Swelling (Sore throat); This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), OROPHARYNGEAL PAIN (Neck Swelling (Sore throat)) and SWELLING (Neck Swelling (Sore throat)) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     NO medical history reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache), OROPHARYNGEAL PAIN (Neck Swelling (Sore throat)) and SWELLING (Neck Swelling (Sore throat)). At the time of the report, HEADACHE (Headache), OROPHARYNGEAL PAIN (Neck Swelling (Sore throat)) and SWELLING (Neck Swelling (Sore throat)) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No relevant concomitant medications were reported.  Treatment details included Advil.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Skin discolouration
Clinical narrative: Toes started having purple blothces; little minor achy; A spontaneous report was received from a consumer concerning a 67-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced pain (little minor achy) and skin discoloration ( toes started having purple blotches,looks like covid toe).  The patient's medical history was not provided. Concomitant medications reported were Vitamin pill, Omeprazole for drug use for unknown indication.  On 16 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 031L20A) through unknown route in the left arm for prophylaxis of COVID-19 infection.  On 16 Feb 2021, the patient experienced little minor achy. On 18 Feb 2021, the patient experienced toes that started having purple blotches and she stated it looks like Covid toe.  Treatment details included None.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events was unknown.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Pain in extremity, Rash, Vaccination site pruritus, Vaccination site rash
Clinical narrative: diagnosed with an allergic reaction; left arm started itching at the injection site; left arm was also sore; rash kept growing; "full on rash"; arm became hot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (left arm started itching at the injection site), PAIN IN EXTREMITY (left arm was also sore), RASH (rash kept growing), VACCINATION SITE RASH ("full on rash") and VACCINATION SITE WARMTH (arm became hot) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (left arm started itching at the injection site), PAIN IN EXTREMITY (left arm was also sore), RASH (rash kept growing), VACCINATION SITE RASH ("full on rash") and VACCINATION SITE WARMTH (arm became hot). On 16-Feb-2021, the patient experienced HYPERSENSITIVITY (diagnosed with an allergic reaction). At the time of the report, VACCINATION SITE PRURITUS (left arm started itching at the injection site), PAIN IN EXTREMITY (left arm was also sore), RASH (rash kept growing), VACCINATION SITE RASH ("full on rash"), VACCINATION SITE WARMTH (arm became hot) and HYPERSENSITIVITY (diagnosed with an allergic reaction) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No relevant concomitant medications were reported.  Treatment details included triamcinolone acetonide cream USP 0.5 %, and oral methylprednisolone tablets USP 4 mg dose pack and Tylenol.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: diagnosed with an allergic reaction; left arm started itching at the injection site; left arm was also sore; rash kept growing; "full on rash"; arm became hot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (left arm started itching at the injection site), PAIN IN EXTREMITY (left arm was also sore), RASH (rash kept growing), VACCINATION SITE RASH ("full on rash") and VACCINATION SITE WARMTH (arm became hot) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (left arm started itching at the injection site), PAIN IN EXTREMITY (left arm was also sore), RASH (rash kept growing), VACCINATION SITE RASH ("full on rash") and VACCINATION SITE WARMTH (arm became hot). On 16-Feb-2021, the patient experienced HYPERSENSITIVITY (diagnosed with an allergic reaction). At the time of the report, VACCINATION SITE PRURITUS (left arm started itching at the injection site), PAIN IN EXTREMITY (left arm was also sore), RASH (rash kept growing), VACCINATION SITE RASH ("full on rash"), VACCINATION SITE WARMTH (arm became hot) and HYPERSENSITIVITY (diagnosed with an allergic reaction) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No relevant concomitant medications were reported.  Treatment details included triamcinolone acetonide cream USP 0.5 %, and oral methylprednisolone tablets USP 4 mg dose pack and Tylenol.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No medical history reported.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown. already had back pain prior but does have a headache    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No relevant concomitant medications were reported.  No treatment information was provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy, Tenderness
Clinical narrative: Lymph node on left side of neck a little swollen (bigger than a half dollar); tenderness on left side of neck, on top of collar bone.; Lymph node a little sore on left side of neck; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Lymph node on left side of neck a little swollen (bigger than a half dollar)), TENDERNESS (tenderness on left side of neck, on top of collar bone.) and LYMPH NODE PAIN (Lymph node a little sore on left side of neck) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for an unknown indication.     No medical history reported.  Concomitant products included ATORVASTATIN and FAMOTIDINE (FAMOTIDIN) for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (Lymph node on left side of neck a little swollen (bigger than a half dollar)), TENDERNESS (tenderness on left side of neck, on top of collar bone.) and LYMPH NODE PAIN (Lymph node a little sore on left side of neck). At the time of the report, LYMPHADENOPATHY (Lymph node on left side of neck a little swollen (bigger than a half dollar)), TENDERNESS (tenderness on left side of neck, on top of collar bone.) and LYMPH NODE PAIN (Lymph node a little sore on left side of neck) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No treatment information was provided.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Indifference, Lymphadenopathy, Swelling face
Clinical narrative: a lymph node in her neck; a swollen lymph node under her right armpit; Headache; her face felt funny on the right side; like her cheek was very heavy; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), INDIFFERENCE (her face felt funny on the right side), SWELLING FACE (like her cheek was very heavy), LYMPHADENOPATHY (a lymph node in her neck) and LYMPHADENOPATHY (a swollen lymph node under her right armpit) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     Concurrent medical conditions included Polycystic ovarian syndrome.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced HEADACHE (Headache), INDIFFERENCE (her face felt funny on the right side) and SWELLING FACE (like her cheek was very heavy). On 12-Feb-2021, the patient experienced LYMPHADENOPATHY (a lymph node in her neck) and LYMPHADENOPATHY (a swollen lymph node under her right armpit). On 11-Feb-2021, HEADACHE (Headache), INDIFFERENCE (her face felt funny on the right side) and SWELLING FACE (like her cheek was very heavy) had resolved. At the time of the report, LYMPHADENOPATHY (a lymph node in her neck) and LYMPHADENOPATHY (a swollen lymph node under her right armpit) had not resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant medications included heart pill and birth control pill for PCOS.  Treatment has not been specified.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Feeling abnormal, Pain
Clinical narrative: Within a half hour the left side of his face and cheek bone had a weird feeling; His legs and  body have been sore; His  joints have been sore; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FEELING ABNORMAL (Within a half hour the left side of his face and cheek bone had a weird feeling), PAIN (His legs and  body have been sore) and ARTHRALGIA (His  joints have been sore) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No medical history reported.  Concomitant products included PREDNISONE for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced FEELING ABNORMAL (Within a half hour the left side of his face and cheek bone had a weird feeling), PAIN (His legs and  body have been sore) and ARTHRALGIA (His  joints have been sore). The patient was treated with PREDNISONE for Pain, at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) for Pain, at an unspecified dose and frequency. On 25-Jan-2021, FEELING ABNORMAL (Within a half hour the left side of his face and cheek bone had a weird feeling) had resolved. At the time of the report, PAIN (His legs and  body have been sore) and ARTHRALGIA (His  joints have been sore) had not resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph nodes in the left side of neck; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swollen lymph nodes in the left side of neck) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No medical history reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (Swollen lymph nodes in the left side of neck). At the time of the report, LYMPHADENOPATHY (Swollen lymph nodes in the left side of neck) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  Concomitant medications have not been specified.  Treatment not provided.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Feeling cold, Hyperglycaemia
Clinical narrative: elevated blood sugars; continues to feel cold; Joint pain in knees; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERGLYCAEMIA (elevated blood sugars), FEELING COLD (continues to feel cold), ARTHRALGIA (Joint pain in knees) and CHILLS (Chills) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Knee replacement. Concomitant products included PROBIOTICS NOS, AZATHIOPRINE SODIUM (IMURAN [AZATHIOPRINE SODIUM]), SITAGLIPTIN PHOSPHATE (JANUVIA [SITAGLIPTIN PHOSPHATE]) and GLYBURIDE for an unknown indication.   On 01-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced HYPERGLYCAEMIA (elevated blood sugars), FEELING COLD (continues to feel cold), ARTHRALGIA (Joint pain in knees) and CHILLS (Chills). At the time of the report, HYPERGLYCAEMIA (elevated blood sugars), FEELING COLD (continues to feel cold), ARTHRALGIA (Joint pain in knees) and CHILLS (Chills) outcome was unknown.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No relevant concomitant medications were reported.    No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: Nausea; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea) and VOMITING (Vomiting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NAUSEA (Nausea) and VOMITING (Vomiting). At the time of the report, NAUSEA (Nausea) and VOMITING (Vomiting) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No relevant concomitant medications were reported.  No treatment details were provided.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Muscle spasms
Clinical narrative: Muscles spasms in legs; Feels weak; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Muscles spasms in legs) and ASTHENIA (Feels weak) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030O20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure and Cholesterol. Concomitant products included VITAMIN D [VITAMIN D NOS], VITAMIN B NOS and CALCIUM for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced MUSCLE SPASMS (Muscles spasms in legs) and ASTHENIA (Feels weak). At the time of the report, MUSCLE SPASMS (Muscles spasms in legs) and ASTHENIA (Feels weak) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant medications reported were blood pressure medicine, pre-diabetic medicine, cholesterol medicine pill and injection. Treatment details included use of natural pills on mouth to lighten the cramps.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Lethargy, Middle insomnia
Clinical narrative: lethargic; warm to touch on injection site; small bump on injection site; waking up during the night; redness in arm on injection site; tiredness; soreness in arm on injection site; body aches; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (lethargic), VACCINATION SITE WARMTH (warm to touch on injection site), VACCINATION SITE MASS (small bump on injection site), MIDDLE INSOMNIA (waking up during the night) and VACCINATION SITE ERYTHEMA (redness in arm on injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included No adverse event and Type 2 diabetes mellitus. Concomitant products included DULAGLUTIDE (TRULICITY) and ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced LETHARGY (lethargic), VACCINATION SITE WARMTH (warm to touch on injection site), VACCINATION SITE MASS (small bump on injection site), MIDDLE INSOMNIA (waking up during the night), VACCINATION SITE ERYTHEMA (redness in arm on injection site), FATIGUE (tiredness), VACCINATION SITE PAIN (soreness in arm on injection site), PAIN (body aches), CHILLS (chills) and PYREXIA (fever). On 15-Feb-2021, PYREXIA (fever) had resolved. At the time of the report, LETHARGY (lethargic), VACCINATION SITE WARMTH (warm to touch on injection site), VACCINATION SITE MASS (small bump on injection site), MIDDLE INSOMNIA (waking up during the night), VACCINATION SITE ERYTHEMA (redness in arm on injection site), FATIGUE (tiredness), VACCINATION SITE PAIN (soreness in arm on injection site), PAIN (body aches) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.8 High.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Treatment details included Tylenol.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Vaccination site erythema, Vaccination site mass, Vaccination site pain
Clinical narrative: lethargic; warm to touch on injection site; small bump on injection site; waking up during the night; redness in arm on injection site; tiredness; soreness in arm on injection site; body aches; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (lethargic), VACCINATION SITE WARMTH (warm to touch on injection site), VACCINATION SITE MASS (small bump on injection site), MIDDLE INSOMNIA (waking up during the night) and VACCINATION SITE ERYTHEMA (redness in arm on injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included No adverse event and Type 2 diabetes mellitus. Concomitant products included DULAGLUTIDE (TRULICITY) and ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced LETHARGY (lethargic), VACCINATION SITE WARMTH (warm to touch on injection site), VACCINATION SITE MASS (small bump on injection site), MIDDLE INSOMNIA (waking up during the night), VACCINATION SITE ERYTHEMA (redness in arm on injection site), FATIGUE (tiredness), VACCINATION SITE PAIN (soreness in arm on injection site), PAIN (body aches), CHILLS (chills) and PYREXIA (fever). On 15-Feb-2021, PYREXIA (fever) had resolved. At the time of the report, LETHARGY (lethargic), VACCINATION SITE WARMTH (warm to touch on injection site), VACCINATION SITE MASS (small bump on injection site), MIDDLE INSOMNIA (waking up during the night), VACCINATION SITE ERYTHEMA (redness in arm on injection site), FATIGUE (tiredness), VACCINATION SITE PAIN (soreness in arm on injection site), PAIN (body aches) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.8 High.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Treatment details included Tylenol.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: lethargic; warm to touch on injection site; small bump on injection site; waking up during the night; redness in arm on injection site; tiredness; soreness in arm on injection site; body aches; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (lethargic), VACCINATION SITE WARMTH (warm to touch on injection site), VACCINATION SITE MASS (small bump on injection site), MIDDLE INSOMNIA (waking up during the night) and VACCINATION SITE ERYTHEMA (redness in arm on injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included No adverse event and Type 2 diabetes mellitus. Concomitant products included DULAGLUTIDE (TRULICITY) and ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced LETHARGY (lethargic), VACCINATION SITE WARMTH (warm to touch on injection site), VACCINATION SITE MASS (small bump on injection site), MIDDLE INSOMNIA (waking up during the night), VACCINATION SITE ERYTHEMA (redness in arm on injection site), FATIGUE (tiredness), VACCINATION SITE PAIN (soreness in arm on injection site), PAIN (body aches), CHILLS (chills) and PYREXIA (fever). On 15-Feb-2021, PYREXIA (fever) had resolved. At the time of the report, LETHARGY (lethargic), VACCINATION SITE WARMTH (warm to touch on injection site), VACCINATION SITE MASS (small bump on injection site), MIDDLE INSOMNIA (waking up during the night), VACCINATION SITE ERYTHEMA (redness in arm on injection site), FATIGUE (tiredness), VACCINATION SITE PAIN (soreness in arm on injection site), PAIN (body aches) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.8 High.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Treatment details included Tylenol.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced VACCINATION SITE RASH ((Rash ) Injection Site). At the time of the report, VACCINATION SITE RASH ((Rash ) Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medicines were not provided  Action taken with mRNA-1273 in response to the event was unknown; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Disorientation, Dizziness, Headache, Muscle spasms, Pain in extremity
Clinical narrative: extremely crampy in her feet/ankles/legs; feeling dizzy; Feeling disoriented; Sneezing non-stop (from her sinuses which gives her a headache); Sneezing non-stop (from her sinuses which gives her a headache); sore arm; This spontaneous case was reported by a physician assistant and describes the occurrence of PAIN IN EXTREMITY (sore arm), MUSCLE SPASMS (extremely crampy in her feet/ankles/legs), DIZZINESS (feeling dizzy), DISORIENTATION (Feeling disoriented) and SNEEZING (Sneezing non-stop (from her sinuses which gives her a headache)) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported.    On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 17-Feb-2021, the patient experienced MUSCLE SPASMS (extremely crampy in her feet/ankles/legs), DIZZINESS (feeling dizzy), DISORIENTATION (Feeling disoriented), SNEEZING (Sneezing non-stop (from her sinuses which gives her a headache)) and HEADACHE (Sneezing non-stop (from her sinuses which gives her a headache)). On 14-Feb-2021, PAIN IN EXTREMITY (sore arm) had resolved. At the time of the report, MUSCLE SPASMS (extremely crampy in her feet/ankles/legs), DIZZINESS (feeling dizzy), DISORIENTATION (Feeling disoriented), SNEEZING (Sneezing non-stop (from her sinuses which gives her a headache)) and HEADACHE (Sneezing non-stop (from her sinuses which gives her a headache)) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Sneezing
Clinical narrative: extremely crampy in her feet/ankles/legs; feeling dizzy; Feeling disoriented; Sneezing non-stop (from her sinuses which gives her a headache); Sneezing non-stop (from her sinuses which gives her a headache); sore arm; This spontaneous case was reported by a physician assistant and describes the occurrence of PAIN IN EXTREMITY (sore arm), MUSCLE SPASMS (extremely crampy in her feet/ankles/legs), DIZZINESS (feeling dizzy), DISORIENTATION (Feeling disoriented) and SNEEZING (Sneezing non-stop (from her sinuses which gives her a headache)) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported.    On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 17-Feb-2021, the patient experienced MUSCLE SPASMS (extremely crampy in her feet/ankles/legs), DIZZINESS (feeling dizzy), DISORIENTATION (Feeling disoriented), SNEEZING (Sneezing non-stop (from her sinuses which gives her a headache)) and HEADACHE (Sneezing non-stop (from her sinuses which gives her a headache)). On 14-Feb-2021, PAIN IN EXTREMITY (sore arm) had resolved. At the time of the report, MUSCLE SPASMS (extremely crampy in her feet/ankles/legs), DIZZINESS (feeling dizzy), DISORIENTATION (Feeling disoriented), SNEEZING (Sneezing non-stop (from her sinuses which gives her a headache)) and HEADACHE (Sneezing non-stop (from her sinuses which gives her a headache)) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, Chills, Dizziness, Fatigue, Feeling cold
Clinical narrative: fast heartrate around 115 BMP as if she was running; Triggered/exaggerated her asthma; shivering; she was very cold; fever of 104 F; massive headache like her head was being split open; extreme massive chills; swelling arm; Feel warm; Felt dizzy; felt very fatigue and sleepy; This spontaneous case was reported by a physician and describes the occurrence of HEART RATE INCREASED (fast heartrate around 115 BMP as if she was running), FEELING COLD (she was very cold) and ASTHMA (Triggered/exaggerated her asthma) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 012M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ZINC SULFATE (LIQUID ZINC), B-vitamin Complex, ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), MULTIVITAMIN & MINERAL, MENAQUINONE-7 (VITAMIN K 2), SELENIUM, PROBIOTIC 10, LEVOTHYROXINE SODIUM (SYNTHROID), Albuterol inhaler and nebulizer and Symbicort                                                      BID for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced HEART RATE INCREASED (fast heartrate around 115 BMP as if she was running), FEELING COLD (she was very cold) and ASTHMA (Triggered/exaggerated her asthma). On 11-Feb-2021, ASTHMA (Triggered/exaggerated her asthma) had resolved. At the time of the report, HEART RATE INCREASED (fast heartrate around 115 BMP as if she was running) and FEELING COLD (she was very cold) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Headache, Heart rate increased, Peripheral swelling, Pyrexia
Clinical narrative: fast heartrate around 115 BMP as if she was running; Triggered/exaggerated her asthma; shivering; she was very cold; fever of 104 F; massive headache like her head was being split open; extreme massive chills; swelling arm; Feel warm; Felt dizzy; felt very fatigue and sleepy; This spontaneous case was reported by a physician and describes the occurrence of HEART RATE INCREASED (fast heartrate around 115 BMP as if she was running), FEELING COLD (she was very cold) and ASTHMA (Triggered/exaggerated her asthma) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 012M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ZINC SULFATE (LIQUID ZINC), B-vitamin Complex, ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), MULTIVITAMIN & MINERAL, MENAQUINONE-7 (VITAMIN K 2), SELENIUM, PROBIOTIC 10, LEVOTHYROXINE SODIUM (SYNTHROID), Albuterol inhaler and nebulizer and Symbicort                                                      BID for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced HEART RATE INCREASED (fast heartrate around 115 BMP as if she was running), FEELING COLD (she was very cold) and ASTHMA (Triggered/exaggerated her asthma). On 11-Feb-2021, ASTHMA (Triggered/exaggerated her asthma) had resolved. At the time of the report, HEART RATE INCREASED (fast heartrate around 115 BMP as if she was running) and FEELING COLD (she was very cold) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 97.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: sore arm; tieredness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and FATIGUE (tieredness) in a 97-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and FATIGUE (tieredness). On 10-Jan-2021, PAIN IN EXTREMITY (sore arm) and FATIGUE (tieredness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was provided. No treatment medication information was provided.   This case was linked to MOD21-020256 (E2B Linked Report).; Sender's Comments:  MOD21-020256:Crosslink
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Dry eye, Eye irritation, Head discomfort, Headache, Nausea
Clinical narrative: Arm was very sore after the second shot; headache; Nausea; Dry, burning eyes; burning eyes; Stuffy head; This spontaneous case was reported by a consumer and describes the occurrence of DRY EYE (Dry, burning eyes), EYE IRRITATION (burning eyes), HEAD DISCOMFORT (Stuffy head), PAIN IN EXTREMITY (Arm was very sore after the second shot) and HEADACHE (headache) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included UTI from 19-Feb-2020 to 02-Dec-2020, Arthritis (more widespread since begining) in 1990, Raynauds in 1993, Peripheral neuropathy (started in one foot, now includes both feet and both legs) in 1998 and Blood pressure since 2015. Concomitant products included NITROFURANTOIN (NITROFURANTOIN "DAK") from 02-Dec-2020 to an unknown date, NAPROXEN, NIFEDIPINE, LEVOTHYROXINE and AMLODIPINE BESYLATE for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Jan-2021, the patient experienced DRY EYE (Dry, burning eyes), EYE IRRITATION (burning eyes), HEAD DISCOMFORT (Stuffy head), HEADACHE (headache) and NAUSEA (Nausea). On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm was very sore after the second shot). On 26-Jan-2021, DRY EYE (Dry, burning eyes) and EYE IRRITATION (burning eyes) had resolved. On 22-Feb-2021, PAIN IN EXTREMITY (Arm was very sore after the second shot) had resolved. At the time of the report, HEAD DISCOMFORT (Stuffy head), HEADACHE (headache) and NAUSEA (Nausea) had not resolved.      Treatments included Pseudoephedrine, acetaminophen and antihistamine   Most recent FOLLOW-UP information incorporated above includes: On 25-Mar-2021: Additional information received; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm was very sore after the second shot; headache; Nausea; Dry, burning eyes; burning eyes; Stuffy head; This spontaneous case was reported by a consumer and describes the occurrence of DRY EYE (Dry, burning eyes), EYE IRRITATION (burning eyes), HEAD DISCOMFORT (Stuffy head), PAIN IN EXTREMITY (Arm was very sore after the second shot) and HEADACHE (headache) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included UTI from 19-Feb-2020 to 02-Dec-2020, Arthritis (more widespread since begining) in 1990, Raynauds in 1993, Peripheral neuropathy (started in one foot, now includes both feet and both legs) in 1998 and Blood pressure since 2015. Concomitant products included NITROFURANTOIN (NITROFURANTOIN "DAK") from 02-Dec-2020 to an unknown date, NAPROXEN, NIFEDIPINE, LEVOTHYROXINE and AMLODIPINE BESYLATE for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Jan-2021, the patient experienced DRY EYE (Dry, burning eyes), EYE IRRITATION (burning eyes), HEAD DISCOMFORT (Stuffy head), HEADACHE (headache) and NAUSEA (Nausea). On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm was very sore after the second shot). On 26-Jan-2021, DRY EYE (Dry, burning eyes) and EYE IRRITATION (burning eyes) had resolved. On 22-Feb-2021, PAIN IN EXTREMITY (Arm was very sore after the second shot) had resolved. At the time of the report, HEAD DISCOMFORT (Stuffy head), HEADACHE (headache) and NAUSEA (Nausea) had not resolved.      Treatments included Pseudoephedrine, acetaminophen and antihistamine   Most recent FOLLOW-UP information incorporated above includes: On 25-Mar-2021: Additional information received; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Pain, Rash
Clinical narrative: Diagnosed with shingles; Serious pain; Rash; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HERPES ZOSTER (Diagnosed with shingles), PAIN (Serious pain) and RASH (Rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (Diagnosed with shingles), PAIN (Serious pain) and RASH (Rash). At the time of the report, HERPES ZOSTER (Diagnosed with shingles), PAIN (Serious pain) and RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.    Most recent FOLLOW-UP information incorporated above includes: On 10-Jun-2021: Follow-up received on 10-JUN-2021 and reporter's causality was updated.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Dyskinesia
Clinical narrative: involuntary movement on the right index finger; This spontaneous case was reported by a consumer and describes the occurrence of DYSKINESIA (involuntary movement on the right index finger) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027620A) for COVID-19 vaccination.     Concomitant products included TERAZOSIN HYDROCHLORIDE (HYTRIN) and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSKINESIA (involuntary movement on the right index finger). At the time of the report, DYSKINESIA (involuntary movement on the right index finger) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Aspirin.  The patient experienced involuntary movement in the index finger on right hand 2 times since receiving dose 1 of the vaccine. It occurred in the middle of the night while sleeping, woke patient up. It takes about 30 minutes to clear up. The reporter was not sure of dates, but last time was approximately 12-Feb-2021.